Aspire Biopharma Holdings Inc. Ordinary Shares - Class A ASBP 深 滬
等待開盤 11-26 09:30:00 美东时间
0.1012
+0.001
+1.20%
華盛通- 最 高0.1042
- 今 開0.099
- 成交量 1062.05万股
- 最 低 0.096
- 昨 收 0.10
- 總市值 501.20万
- 52周最高 15.80
- 市盈率 靜 --
- 換手率 21.44%
- 52周最低 0.088
- 委 比 88.24%
- 總股本 4952.60万
- 歷史最高 15.80
- 量 比 0.16
- 振 幅 8.20%
- 歷史最低 0.088
- 每 手 1
- 風險率 4.65%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Why Gorilla Technology Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Shares of Gorilla Technology Group Inc. (NASDAQ:GRRR) rose sharply in pre-marke...
11-18 19:10
Aspire Biopharma Hldgs Q3 EPS $(0.04) Down From $(0.01) YoY, Sales $1.941K
Aspire Biopharma Hldgs (NASDAQ:ASBP) reported quarterly losses of $(0.04) per share. This is a 300 percent decrease over losses of $(0.01) per share from the same period last year. The company reported $1.941 thousand
11-14 22:31
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers MSP Recovery (NASDAQ:MSPR) shares rose 93.0% to $0.61 during Tuesday's...
11-11 20:07
Why Rocket Lab Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
Shares of Rocket Lab Corp (NASDAQ:RKLB) rose sharply in pre-market trading afte...
11-11 18:55
Aspire Biopharma Showcases Sublingual High-Dose Aspirin At CPHI Frankfurt
Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug delivery technology, today announced its successful participation in the CPHI Frankfurt trade
11-06 22:12
Aspire Biopharma Faces Nasdaq Delisting Notice
An update from Aspire Biopharma Holdings ( ($ASBP) ) is now available. Aspire B...
10-18 05:51
Nasdaq Surges 100 Points; AngioDynamics Posts Upbeat Q1 Results
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more ...
10-02 21:44
Aspire Biopharma Holdings shares are trading higher after the company announced a milestone roadmap targeting H2 2025 FDA Submission for Sublingual Asprin and 2026 milestones for Needle-Free Semaglutide and more-rapid ED medication.
Aspire Biopharma Holdings shares are trading higher after the company announced...
10-02 00:40
Aspire Biopharma Provides Pipeline Schedule
Anticipated Upcoming MilestonesSublingual High-dose Aspirin (Lead Program)H2 2025: Request meeting with FDA to discuss 505(b)(2) pathway.H2 2025: Target submission of New Drug Application (NDA).Sublingual ED medicationH1
10-01 20:39
Aspire Biopharma Expands BUZZ BOMB Pre-Workout Production With New SupraNaturals Manufacturing Agreement To Meet Growing Market Demand
Part of New Contract Manufacturing Agreement with SupraNaturals to Secure Additional Production CapacitySupraNaturals is a leading private label manufacturer in the health and wellness industryBUZZ BOMB™
09-16 20:37
